BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Science in Boston - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://scienceinboston.com
X-WR-CALDESC:Events for Science in Boston
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20180311T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20181104T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191211T080000
DTEND;TZID=America/New_York:20191211T100000
DTSTAMP:20260716T161944
CREATED:20191125T160127Z
LAST-MODIFIED:20191125T160127Z
UID:7336-1576051200-1576058400@scienceinboston.com
SUMMARY:Building A Bulletproof Communications & Crisis Management Strategy
DESCRIPTION:How to navigate a crisis? In a time characterized by online activism and hyper-polarization\, where health is politicized and corporate America is scrutinized\, the potential for a crisis lurks in the shadows for every healthcare company. No matter the size or specialty\, every company has its own unique set of risks\, some of which are predictable and many of which are not. \nSo how do you identify and mitigate risks early\, before a company’s crisis has made it to the front page of the Wall Street Journal? And how do you find the resources and time for that work when your team is small and already busy? \nJoin us for a lively discussion with cross-functional leaders on how companies can identify and plan for the issues that are relevant to their business. Whether it’s avoiding a social media firestorm\, managing grassroots activism from patients advocates\, or navigating data privacy issues; our esteemed panelists will be ready to share their experiences and answer your questions based on their vast array of experiences. \nSponsored by the Marketing Communications (MARCOM) Forum Working Group.
URL:https://scienceinboston.com/event/building-a-bulletproof-communications-crisis-management-strategy/
LOCATION:MassBio\, 300 Technology Square 8th Fl\, Cambridge\, MA\, 02139\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191211T080000
DTEND;TZID=America/New_York:20191211T100000
DTSTAMP:20260716T161944
CREATED:20191125T160127Z
LAST-MODIFIED:20191125T160127Z
UID:27404-1576051200-1576058400@scienceinboston.com
SUMMARY:Building A Bulletproof Communications & Crisis Management Strategy
DESCRIPTION:How to navigate a crisis? In a time characterized by online activism and hyper-polarization\, where health is politicized and corporate America is scrutinized\, the potential for a crisis lurks in the shadows for every healthcare company. No matter the size or specialty\, every company has its own unique set of risks\, some of which are predictable and many of which are not. \nSo how do you identify and mitigate risks early\, before a company’s crisis has made it to the front page of the Wall Street Journal? And how do you find the resources and time for that work when your team is small and already busy? \nJoin us for a lively discussion with cross-functional leaders on how companies can identify and plan for the issues that are relevant to their business. Whether it’s avoiding a social media firestorm\, managing grassroots activism from patients advocates\, or navigating data privacy issues; our esteemed panelists will be ready to share their experiences and answer your questions based on their vast array of experiences. \nSponsored by the Marketing Communications (MARCOM) Forum Working Group.
URL:https://scienceinboston.com/event/building-a-bulletproof-communications-crisis-management-strategy-2/
LOCATION:MassBio\, 300 Technology Square 8th Fl\, Cambridge\, MA\, 02139\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191211T080000
DTEND;TZID=America/New_York:20191211T170000
DTSTAMP:20260716T161944
CREATED:20191125T160310Z
LAST-MODIFIED:20191125T160310Z
UID:7338-1576051200-1576083600@scienceinboston.com
SUMMARY:Developing Innovative Leaders in Biotech
DESCRIPTION:Overview\n\nIndividuals and teams drive innovation throughout the biomedical industry\, from discovery research to clinical trials\, product development and the larger market. Because of the risks inherent in this process\, there is great interest in cultivating individual and team behaviors to try to make innovation more systematic. \nIn this webinar\, Jeff Karp\, PhD\, will draw upon his history of bridging academia and industry\, starting six companies (including the newly public Frequency Therapeutics)\, creating multiple products and raising more than $300 million dollars in venture and philanthropic funding. He will discuss ways to encourage creativity and individual empowerment in your team\, and utilize your network to efficiently socialize ideas and identify strategic priorities.
URL:https://scienceinboston.com/event/developing-innovative-leaders-in-biotech/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191211T080000
DTEND;TZID=America/New_York:20191211T170000
DTSTAMP:20260716T161944
CREATED:20191125T160310Z
LAST-MODIFIED:20191125T160310Z
UID:27405-1576051200-1576083600@scienceinboston.com
SUMMARY:Developing Innovative Leaders in Biotech
DESCRIPTION:Overview\n\nIndividuals and teams drive innovation throughout the biomedical industry\, from discovery research to clinical trials\, product development and the larger market. Because of the risks inherent in this process\, there is great interest in cultivating individual and team behaviors to try to make innovation more systematic. \nIn this webinar\, Jeff Karp\, PhD\, will draw upon his history of bridging academia and industry\, starting six companies (including the newly public Frequency Therapeutics)\, creating multiple products and raising more than $300 million dollars in venture and philanthropic funding. He will discuss ways to encourage creativity and individual empowerment in your team\, and utilize your network to efficiently socialize ideas and identify strategic priorities.
URL:https://scienceinboston.com/event/developing-innovative-leaders-in-biotech-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191211T173000
DTEND;TZID=America/New_York:20191211T203000
DTSTAMP:20260716T161944
CREATED:20191125T160604Z
LAST-MODIFIED:20191125T160852Z
UID:7340-1576085400-1576096200@scienceinboston.com
SUMMARY:Women in Bio: 2019 Annual Wine & Chocolate Holiday Party
DESCRIPTION:Overview\nThe WIB-Greater Boston chapter will be celebrating the holiday season at The Allsteel on December 11\, 2019\, in Boston. Join us for a night of wine\, chocolate\, and cheer as we bid farewell to 2019 and look ahead to another successful year in the hub! \nTo register\, visit: https://www.womeninbio.org/events/EventDetails.aspx?id=1296476&group= \nProgram \n5:30 p.m. – Registration opens\n5:30 p.m. – 8:30 p.m.: Food\, drinks\, and networking \nPricing Information* \n\nMembers: $15\nNon-Members/Free Unlimited Guest Members*: $30\n\n*To access the Member rate\, click here to purchase a WIB membership. \nSpecial Pricing for Guests \nMembers can register guests at member price. \nWalk-Ins Accepted? \nYes* \n* – Walk-ins will be accepted until event capacity is reached \nMaximum Capacity \n60 \nParking Information \nParking available at State Street garage and other nearby garages. \nDirections from Public Transit \nRed line to State Street
URL:https://scienceinboston.com/event/women-in-bio-2019-annual-wine-chocolate-holiday-party/
LOCATION:Allsteel\, 200 State Street #400\, Boston\, MA\, 02109\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191211T173000
DTEND;TZID=America/New_York:20191211T203000
DTSTAMP:20260716T161944
CREATED:20191125T160604Z
LAST-MODIFIED:20191125T160604Z
UID:27406-1576085400-1576096200@scienceinboston.com
SUMMARY:Women in Bio: 2019 Annual Wine & Chocolate Holiday Party
DESCRIPTION:Overview\nThe WIB-Greater Boston chapter will be celebrating the holiday season at The Allsteel on December 11\, 2019\, in Boston. Join us for a night of wine\, chocolate\, and cheer as we bid farewell to 2019 and look ahead to another successful year in the hub! \nTo register\, visit: https://www.womeninbio.org/events/EventDetails.aspx?id=1296476&group= \nProgram \n5:30 p.m. – Registration opens\n5:30 p.m. – 8:30 p.m.: Food\, drinks\, and networking \nPricing Information* \n\nMembers: $15\nNon-Members/Free Unlimited Guest Members*: $30\n\n*To access the Member rate\, click here to purchase a WIB membership. \nSpecial Pricing for Guests \nMembers can register guests at member price. \nWalk-Ins Accepted? \nYes* \n* – Walk-ins will be accepted until event capacity is reached \nMaximum Capacity \n60 \nParking Information \nParking available at State Street garage and other nearby garages. \nDirections from Public Transit \nRed line to State Street
URL:https://scienceinboston.com/event/women-in-bio-2019-annual-wine-chocolate-holiday-party-2/
LOCATION:Allsteel\, 200 State Street #400\, Boston\, MA\, 02109\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191212T081500
DTEND;TZID=America/New_York:20191212T160000
DTSTAMP:20260716T161944
CREATED:20191125T160803Z
LAST-MODIFIED:20191125T160803Z
UID:7343-1576138500-1576166400@scienceinboston.com
SUMMARY:Live-Stream at M2D2: The Massachusetts Conference for Women
DESCRIPTION:Overview\n\nCome join us at M2D2 for a Live-Stream of the Massachusetts Conference for Women! \nThe Massachusetts Conference for Women provides one full day of connection\, motivation\, networking\, inspiration and skill building for thousands of women each year. Since the first Conference in 2005\, this annual event has grown to a sold-out crowd of more than 10\,000 attendees and impacts thousands of lives. Dozens of expert speakers lead workshops and seminars on the issues that matter most to women\, including personal finance\, business and entrepreneurship\, health\, work/life balance and more. The Conference offers incredible opportunities for business networking\, professional development and personal growth.
URL:https://scienceinboston.com/event/live-stream-at-m2d2-the-massachusetts-conference-for-women/
LOCATION:M2D2\, 110 Canal Street\, 4th Floor\, Lowell\, MA\, 01854\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191212T081500
DTEND;TZID=America/New_York:20191212T160000
DTSTAMP:20260716T161944
CREATED:20191125T160803Z
LAST-MODIFIED:20191125T160803Z
UID:27407-1576138500-1576166400@scienceinboston.com
SUMMARY:Live-Stream at M2D2: The Massachusetts Conference for Women
DESCRIPTION:Overview\n\nCome join us at M2D2 for a Live-Stream of the Massachusetts Conference for Women! \nThe Massachusetts Conference for Women provides one full day of connection\, motivation\, networking\, inspiration and skill building for thousands of women each year. Since the first Conference in 2005\, this annual event has grown to a sold-out crowd of more than 10\,000 attendees and impacts thousands of lives. Dozens of expert speakers lead workshops and seminars on the issues that matter most to women\, including personal finance\, business and entrepreneurship\, health\, work/life balance and more. The Conference offers incredible opportunities for business networking\, professional development and personal growth.
URL:https://scienceinboston.com/event/live-stream-at-m2d2-the-massachusetts-conference-for-women-2/
LOCATION:M2D2\, 110 Canal Street\, 4th Floor\, Lowell\, MA\, 01854\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191212T170000
DTEND;TZID=America/New_York:20191212T200000
DTSTAMP:20260716T161944
CREATED:20191125T161144Z
LAST-MODIFIED:20191125T161144Z
UID:7345-1576170000-1576180800@scienceinboston.com
SUMMARY:2019 Annual Holiday Party
DESCRIPTION:Winter is in the air! And with cold weather and sweaters comes MassBio’s most anticipated mixer of the year – our 2019 Annual Holiday Party. \nKick off the season with MassBio at our holiday celebration at the Hyatt Regency on December 12. This premier event gathers 800+ guests from MassBio’s member companies. Bring a colleague or make a few new friends while celebrating the holiday season. \nThis event is members only.
URL:https://scienceinboston.com/event/2019-annual-holiday-party/
LOCATION:Hyatt Regency Cambridge\, 575 Memorial Drive\, Cambridge\, MA\, 02139\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191212T170000
DTEND;TZID=America/New_York:20191212T200000
DTSTAMP:20260716T161944
CREATED:20191125T161144Z
LAST-MODIFIED:20191125T161144Z
UID:27408-1576170000-1576180800@scienceinboston.com
SUMMARY:2019 Annual Holiday Party
DESCRIPTION:Winter is in the air! And with cold weather and sweaters comes MassBio’s most anticipated mixer of the year – our 2019 Annual Holiday Party. \nKick off the season with MassBio at our holiday celebration at the Hyatt Regency on December 12. This premier event gathers 800+ guests from MassBio’s member companies. Bring a colleague or make a few new friends while celebrating the holiday season. \nThis event is members only.
URL:https://scienceinboston.com/event/2019-annual-holiday-party-2/
LOCATION:Hyatt Regency Cambridge\, 575 Memorial Drive\, Cambridge\, MA\, 02139\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191216T090000
DTEND;TZID=America/New_York:20191217T163000
DTSTAMP:20260716T161944
CREATED:20191125T161328Z
LAST-MODIFIED:20191125T161646Z
UID:7348-1576486800-1576600200@scienceinboston.com
SUMMARY:Biotech 101: The Science & Business of Biotech\, Dec 2019
DESCRIPTION:Overview\n\nNew to the life sciences industry? Do you need to have a better understanding of the science and business models driving the industry? Biotech 101: The Science of Biotech & The Business of Biotech provides a thorough overview of the industry at a reduced cost. The program covers two full days of biotechnology information for non-science professionals who may be working or looking to work in the biopharmaceutical industry. \nTarget Audience:\n\nNon-science professionals from all sectors of the biotech\, pharma\, and life sciences industries\, including: sales\, marketing\, HR\, legal\, manufacturing\, business development\, finance\, management\, government relations\, IT\, safety\, tech transfer offices\nPatient advocacy groups\, disease foundations\nPolicy makers\, lobbyists\, attorneys\nVenture capitalists\, angel investors\, banks\, analysts\, financial managers\nInsurance brokers\, real estate professionals\nConsultants\, public relations specialists\, journalists\nUniversity administrators\, research institute support staff\nEnvironmental & Health & Safety Engineers\n\nDay 1 \nWhat is the science behind biotechnology? Explore the key concepts on which the industry is built through hands-on activities and simple lab techniques. This program is designed to provide non-science professionals with a better understanding of the molecular biology that drives the production of most biopharmaceutical products and to help them better understand the research activities in their organizations. \nIn this course you will learn: How medicines made through biotechnology differ from other medicines\, what DNA does\, how the body makes proteins\, how genetic engineering works\, what personalized medicine is\, and how proteins are made in the lab.  Participants will perform agarose gel electrophoresis and protein purification. \nDay 2 \nThe Business of Biotech explores the business considerations that drive company strategies. Gain a deeper understanding of how companies are funded\, which government agencies regulate the sector and how different departments need to be aligned to be successful. This day provides an overview of how the industry works\, why it works the way it does\, and how the industry may change in the years ahead. For those considering careers in the biopharma space or transitioning from the science and technical aspects of the industry to the business side\, this course delivers a sound\, basic understanding of the “business of biotech”. \nCourse content includes: From Discovery to Commercialization\, Role of Non-profit Basic Research\, Intellectual Property Considerations & Funding Sources\, Organizational Characteristics\, and The Ecosystem and the Future of Biopharma \nInstructors:\nMichelle Mischke\, PhD is the Director of Biotechnology Education Programs at MassBioEd. She has extensive research\, teaching\, and administrative experience. She taught a range of undergraduate biology courses at MIT and was a course coordinator and content developer for 7.00x\, the first large online biology course offered by edX. While at MIT\, she was involved in K-12 science outreach and education programs. Michelle holds a B.A. in both Biology and Chemistry from Colorado State University and a Ph.D. in Pharmacology from the University of Medicine and Dentistry of New Jersey. Prior to joining the Department of Biology at MIT\, she worked as a postdoctoral fellow at Harvard University. \nImran Nasrullah\, MS\, JD\, CLP has twenty years of experience in biopharmaceutical business development\, licensing\, and economic development experience. Currently he serves as Director of Innovation Sourcing at Boehringer Ingelheim\, where he facilitates access to new scientific innovation emerging from the Boston area and forges business relationships within the Boston Cambridge life-science ecosystem. He served on the Senior Advisory Board for Cellanyx after heading strategic alliances and business development for T1D First\, a disease foundation dedicated to curing Type 1 Diabetes. As Head of Strategic Alliances\, he led industry\, academic and not-for-profit partnerships. Prior to T1D First\, Imran served as CBO at MassBio\, where he built MassBio’s business & investor and economic development outreach programs – known as MassBio Innovation Services – to help companies raise capital and identify strategic partnering and licensing opportunities. Up until then\, Imran worked for ten years in the biopharmaceutical industry as directors of business development and licensing for Genzyme Corporation\, Millennium Pharmaceuticals. Imran started his licensing career working for Mayo Clinic and then later\, the Dana Farber Cancer Institute. Imran is author to several publications regarding the impact of exercise on auto-immune disease patients. He received the 2010 Outstanding 50 Asian American Business awardee. Imran received his MS in Physiology at the University of Colorado and his BS in Exercise Physiology at the University of Massachusetts Amherst. He holds a JD in Intellectual Property and Licensing from Suffolk University Law School.
URL:https://scienceinboston.com/event/biotech-101-the-science-business-of-biotech-dec-2019/
LOCATION:MassBio\, 300 Technology Square 8th Fl\, Cambridge\, MA\, 02139\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191216T090000
DTEND;TZID=America/New_York:20191217T163000
DTSTAMP:20260716T161944
CREATED:20191125T161328Z
LAST-MODIFIED:20191125T161328Z
UID:27409-1576486800-1576600200@scienceinboston.com
SUMMARY:Biotech 101: The Science & Business of Biotech\, Dec 2019
DESCRIPTION:Overview\n\nNew to the life sciences industry? Do you need to have a better understanding of the science and business models driving the industry? Biotech 101: The Science of Biotech & The Business of Biotech provides a thorough overview of the industry at a reduced cost. The program covers two full days of biotechnology information for non-science professionals who may be working or looking to work in the biopharmaceutical industry. \nTarget Audience:\n\nNon-science professionals from all sectors of the biotech\, pharma\, and life sciences industries\, including: sales\, marketing\, HR\, legal\, manufacturing\, business development\, finance\, management\, government relations\, IT\, safety\, tech transfer offices\nPatient advocacy groups\, disease foundations\nPolicy makers\, lobbyists\, attorneys\nVenture capitalists\, angel investors\, banks\, analysts\, financial managers\nInsurance brokers\, real estate professionals\nConsultants\, public relations specialists\, journalists\nUniversity administrators\, research institute support staff\nEnvironmental & Health & Safety Engineers\n\nDay 1 \nWhat is the science behind biotechnology? Explore the key concepts on which the industry is built through hands-on activities and simple lab techniques. This program is designed to provide non-science professionals with a better understanding of the molecular biology that drives the production of most biopharmaceutical products and to help them better understand the research activities in their organizations. \nIn this course you will learn: How medicines made through biotechnology differ from other medicines\, what DNA does\, how the body makes proteins\, how genetic engineering works\, what personalized medicine is\, and how proteins are made in the lab.  Participants will perform agarose gel electrophoresis and protein purification. \nDay 2 \nThe Business of Biotech explores the business considerations that drive company strategies. Gain a deeper understanding of how companies are funded\, which government agencies regulate the sector and how different departments need to be aligned to be successful. This day provides an overview of how the industry works\, why it works the way it does\, and how the industry may change in the years ahead. For those considering careers in the biopharma space or transitioning from the science and technical aspects of the industry to the business side\, this course delivers a sound\, basic understanding of the “business of biotech”. \nCourse content includes: From Discovery to Commercialization\, Role of Non-profit Basic Research\, Intellectual Property Considerations & Funding Sources\, Organizational Characteristics\, and The Ecosystem and the Future of Biopharma \nInstructors:\nMichelle Mischke\, PhD is the Director of Biotechnology Education Programs at MassBioEd. She has extensive research\, teaching\, and administrative experience. She taught a range of undergraduate biology courses at MIT and was a course coordinator and content developer for 7.00x\, the first large online biology course offered by edX. While at MIT\, she was involved in K-12 science outreach and education programs. Michelle holds a B.A. in both Biology and Chemistry from Colorado State University and a Ph.D. in Pharmacology from the University of Medicine and Dentistry of New Jersey. Prior to joining the Department of Biology at MIT\, she worked as a postdoctoral fellow at Harvard University. \nImran Nasrullah\, MS\, JD\, CLP has twenty years of experience in biopharmaceutical business development\, licensing\, and economic development experience. Currently he serves as Director of Innovation Sourcing at Boehringer Ingelheim\, where he facilitates access to new scientific innovation emerging from the Boston area and forges business relationships within the Boston Cambridge life-science ecosystem. He served on the Senior Advisory Board for Cellanyx after heading strategic alliances and business development for T1D First\, a disease foundation dedicated to curing Type 1 Diabetes. As Head of Strategic Alliances\, he led industry\, academic and not-for-profit partnerships. Prior to T1D First\, Imran served as CBO at MassBio\, where he built MassBio’s business & investor and economic development outreach programs – known as MassBio Innovation Services – to help companies raise capital and identify strategic partnering and licensing opportunities. Up until then\, Imran worked for ten years in the biopharmaceutical industry as directors of business development and licensing for Genzyme Corporation\, Millennium Pharmaceuticals. Imran started his licensing career working for Mayo Clinic and then later\, the Dana Farber Cancer Institute. Imran is author to several publications regarding the impact of exercise on auto-immune disease patients. He received the 2010 Outstanding 50 Asian American Business awardee. Imran received his MS in Physiology at the University of Colorado and his BS in Exercise Physiology at the University of Massachusetts Amherst. He holds a JD in Intellectual Property and Licensing from Suffolk University Law School.
URL:https://scienceinboston.com/event/biotech-101-the-science-business-of-biotech-dec-2019-2/
LOCATION:MassBio\, 300 Technology Square 8th Fl\, Cambridge\, MA\, 02139\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191218T080000
DTEND;TZID=America/New_York:20191218T100000
DTSTAMP:20260716T161944
CREATED:20191125T161607Z
LAST-MODIFIED:20191125T161607Z
UID:7351-1576656000-1576663200@scienceinboston.com
SUMMARY:Fireside Chat with Stiris Research’s Experts on Health Authority Inspection
DESCRIPTION:Description\nHealth authority inspections evoke reactions that are situated somewhere on the spectrum between panic to preparedness. Between innovative studies\, collaborating with vendors\, and supporting your clinical trial sites\, there is a multitude of scenarios where you may find yourself questioning your inspection preparedness. Organizations want to know: where can things go wrong and how do we set ourselves up for the best results? \nStiris’ QA Expert\, Kara Lee McWatters\, and President & CEO\, Shantal Feltham\, will discuss common findings from health authority inspections\, how to avoid pitfalls during an inspection\, day-to-day strategies you can implement\, challenges\, successes\, and real-life anecdotes to help you be inspection ready. Following the fireside chat\, there will be an open Q&A forum\, where you’ll have the opportunity to dig deeper into the information provided or ask your own questions. \nWant to guarantee your inspection question gets addressed? Submit ALL your questions via email at Auditing@StirisResearch.com or on Twitter @StirisResearch. \nStiris Research is a MassBIO member. MassBio Forums are networking and professional development that is planned for members by members to discuss industry hot topics\, tackle common challenges and share best practices. For those who cannot make it to Cambridge\, MassBio also webcasts all presentations live and archives the videos for on-demand replay in the Knowledge Base. See massbio.org for more information
URL:https://scienceinboston.com/event/fireside-chat-with-stiris-researchs-experts-on-health-authority-inspection/
LOCATION:MassBio\, 300 Technology Square 8th Fl\, Cambridge\, MA\, 02139\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191218T080000
DTEND;TZID=America/New_York:20191218T100000
DTSTAMP:20260716T161944
CREATED:20191125T161607Z
LAST-MODIFIED:20191125T161607Z
UID:27410-1576656000-1576663200@scienceinboston.com
SUMMARY:Fireside Chat with Stiris Research’s Experts on Health Authority Inspection
DESCRIPTION:Description\nHealth authority inspections evoke reactions that are situated somewhere on the spectrum between panic to preparedness. Between innovative studies\, collaborating with vendors\, and supporting your clinical trial sites\, there is a multitude of scenarios where you may find yourself questioning your inspection preparedness. Organizations want to know: where can things go wrong and how do we set ourselves up for the best results? \nStiris’ QA Expert\, Kara Lee McWatters\, and President & CEO\, Shantal Feltham\, will discuss common findings from health authority inspections\, how to avoid pitfalls during an inspection\, day-to-day strategies you can implement\, challenges\, successes\, and real-life anecdotes to help you be inspection ready. Following the fireside chat\, there will be an open Q&A forum\, where you’ll have the opportunity to dig deeper into the information provided or ask your own questions. \nWant to guarantee your inspection question gets addressed? Submit ALL your questions via email at Auditing@StirisResearch.com or on Twitter @StirisResearch. \nStiris Research is a MassBIO member. MassBio Forums are networking and professional development that is planned for members by members to discuss industry hot topics\, tackle common challenges and share best practices. For those who cannot make it to Cambridge\, MassBio also webcasts all presentations live and archives the videos for on-demand replay in the Knowledge Base. See massbio.org for more information
URL:https://scienceinboston.com/event/fireside-chat-with-stiris-researchs-experts-on-health-authority-inspection-2/
LOCATION:MassBio\, 300 Technology Square 8th Fl\, Cambridge\, MA\, 02139\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191222T180000
DTEND;TZID=America/New_York:20191222T200000
DTSTAMP:20260716T161944
CREATED:20191209T231436Z
LAST-MODIFIED:20191209T231436Z
UID:7524-1577037600-1577044800@scienceinboston.com
SUMMARY:Going Beyond the Gut: The Future of Microbiome Therapeutics
DESCRIPTION:Overview\n\nThe microbiome market is one of the hottest areas for innovation in the life sciences space.  We are seeing an uptick in both research and venture capital dollars going into the microbiome industry—both in humans and plants.  As a result\, the global microbiome market is expected to grow from $235.8 million in 2018 to $521.23 million by 2022. \nPlease join us for a panel discussion led by some of Boston’s most innovative companies in the space to learn about the science behind the microbiome\, the utilization of emerging technologies\, and various perspectives on the future of the industry. \nConfirmed Speakers \nRyan Barrett\, VP\, Corporate Development & IP\,  Axial Biotherapeutics \nDr. Martha Herbert \, Assistant Professor of Neurology\, Harvard Medical School\, Pediatric Neurologist and Neuroscientist\,  Massachusetts General Hospital \nGeoff van Maltzahn\, Co-founder and Chief Innovation Officer\,  Indigo
URL:https://scienceinboston.com/event/going-beyond-the-gut-the-future-of-microbiome-therapeutics/
LOCATION:Broad Institute of MIT and Harvard\, 415 Main Street Auditorium\, Cambridge\, MA\, 02142\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20191222T180000
DTEND;TZID=America/New_York:20191222T200000
DTSTAMP:20260716T161944
CREATED:20191209T231436Z
LAST-MODIFIED:20191209T231436Z
UID:27419-1577037600-1577044800@scienceinboston.com
SUMMARY:Going Beyond the Gut: The Future of Microbiome Therapeutics
DESCRIPTION:Overview\n\nThe microbiome market is one of the hottest areas for innovation in the life sciences space.  We are seeing an uptick in both research and venture capital dollars going into the microbiome industry—both in humans and plants.  As a result\, the global microbiome market is expected to grow from $235.8 million in 2018 to $521.23 million by 2022. \nPlease join us for a panel discussion led by some of Boston’s most innovative companies in the space to learn about the science behind the microbiome\, the utilization of emerging technologies\, and various perspectives on the future of the industry. \nConfirmed Speakers \nRyan Barrett\, VP\, Corporate Development & IP\,  Axial Biotherapeutics \nDr. Martha Herbert \, Assistant Professor of Neurology\, Harvard Medical School\, Pediatric Neurologist and Neuroscientist\,  Massachusetts General Hospital \nGeoff van Maltzahn\, Co-founder and Chief Innovation Officer\,  Indigo
URL:https://scienceinboston.com/event/going-beyond-the-gut-the-future-of-microbiome-therapeutics-3/
LOCATION:Broad Institute of MIT and Harvard\, 415 Main Street Auditorium\, Cambridge\, MA\, 02142\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200107T083000
DTEND;TZID=America/New_York:20200107T213000
DTSTAMP:20260716T161944
CREATED:20191209T224236Z
LAST-MODIFIED:20191209T224236Z
UID:7507-1578385800-1578432600@scienceinboston.com
SUMMARY:Harvard Medical School Master’s Degree Info Session
DESCRIPTION:Overview\n\nHarvard Medical School Postgraduate Medical Education Admissions team will host an online information session for three masters’ programs: Master in Clinical Service Operations\, Master of Healthcare Quality and Safety and Master of Medical Sciences in Clinical Investigation. \nHarvard Medical School faculty created these Master Degree Programs to address the needs of clinicians\, clinician-scientists and administrators in the areas of patient-oriented research\, and health care quality and safety. All three degrees combine innovative forms of pedagogy from leading Harvard faculty with an individual mentor experience in a Harvard affiliated laboratory or with a practical application at Harvard’s academic medical centers and community hospitals. \nAll degree programs prepare clinicians to assume leadership roles in their place of employment and to lead high profile projects.
URL:https://scienceinboston.com/event/harvard-medical-school-masters-degree-info-session/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200107T083000
DTEND;TZID=America/New_York:20200107T213000
DTSTAMP:20260716T161944
CREATED:20191209T224236Z
LAST-MODIFIED:20191209T224236Z
UID:27412-1578385800-1578432600@scienceinboston.com
SUMMARY:Harvard Medical School Master’s Degree Info Session
DESCRIPTION:Overview\n\nHarvard Medical School Postgraduate Medical Education Admissions team will host an online information session for three masters’ programs: Master in Clinical Service Operations\, Master of Healthcare Quality and Safety and Master of Medical Sciences in Clinical Investigation. \nHarvard Medical School faculty created these Master Degree Programs to address the needs of clinicians\, clinician-scientists and administrators in the areas of patient-oriented research\, and health care quality and safety. All three degrees combine innovative forms of pedagogy from leading Harvard faculty with an individual mentor experience in a Harvard affiliated laboratory or with a practical application at Harvard’s academic medical centers and community hospitals. \nAll degree programs prepare clinicians to assume leadership roles in their place of employment and to lead high profile projects.
URL:https://scienceinboston.com/event/harvard-medical-school-masters-degree-info-session-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200108T170000
DTEND;TZID=America/New_York:20200108T203000
DTSTAMP:20260716T161944
CREATED:20191209T224435Z
LAST-MODIFIED:20191209T224435Z
UID:7509-1578502800-1578515400@scienceinboston.com
SUMMARY:Post-Seed Venture Capital: What Is It? Is it Right for Me?
DESCRIPTION:Overview\n\nStartups: If you’re committed to your business vision\, then you MUST start planning for venture financing. \nEven if your startup is brand-new\, NOW is the time to map out your complete business growth path — all the way to venture financing. \nGet a crystal-clear picture of the process as we welcome three noted life science business financing experts to our Lowell center after work on Wednesday\, January 8. \nJoin us and: \n\nUnderstand how venture financing works today.\nLearn what to look for (and look OUT for) in a VC offer.\nLearn how to prepare your full business financing plan—from angel investors to VCs.\nFind out the preparations you need to make to advance to each stage of financing.\nGet expert answers to all your business financing questions.\nNetwork with VCs\, other investors\, and your entrepreneur peers.\nEnjoy complimentary snacks and beverages.\n\nPLUS\, practice and improve your pitch! \nCome with your pitch deck\, because you can enter your name to give your business presentation and get valuable feedback from our panel. \nAgenda: \n5:00 – Registration & Networking w/ food & drink \n5:30 – Fireside Chat with Bill Yelle\, Nancy Briefs\, and moderator Vinit Nijhawan. \n6:30 – Q&A and Networking \n  \nOnline tickets: $10.00 \nWalk-ins: $20.00 \n*This event will also include a 200k Challenge 2019 Info Session* \n*Free parking included*
URL:https://scienceinboston.com/event/post-seed-venture-capital-what-is-it-is-it-right-for-me/
LOCATION:M2D2\, 110 Canal Street\, 4th Floor\, Lowell\, MA\, 01854\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200108T170000
DTEND;TZID=America/New_York:20200108T203000
DTSTAMP:20260716T161944
CREATED:20191209T224435Z
LAST-MODIFIED:20191209T224435Z
UID:27413-1578502800-1578515400@scienceinboston.com
SUMMARY:Post-Seed Venture Capital: What Is It? Is it Right for Me?
DESCRIPTION:Overview\n\nStartups: If you’re committed to your business vision\, then you MUST start planning for venture financing. \nEven if your startup is brand-new\, NOW is the time to map out your complete business growth path — all the way to venture financing. \nGet a crystal-clear picture of the process as we welcome three noted life science business financing experts to our Lowell center after work on Wednesday\, January 8. \nJoin us and: \n\nUnderstand how venture financing works today.\nLearn what to look for (and look OUT for) in a VC offer.\nLearn how to prepare your full business financing plan—from angel investors to VCs.\nFind out the preparations you need to make to advance to each stage of financing.\nGet expert answers to all your business financing questions.\nNetwork with VCs\, other investors\, and your entrepreneur peers.\nEnjoy complimentary snacks and beverages.\n\nPLUS\, practice and improve your pitch! \nCome with your pitch deck\, because you can enter your name to give your business presentation and get valuable feedback from our panel. \nAgenda: \n5:00 – Registration & Networking w/ food & drink \n5:30 – Fireside Chat with Bill Yelle\, Nancy Briefs\, and moderator Vinit Nijhawan. \n6:30 – Q&A and Networking \n  \nOnline tickets: $10.00 \nWalk-ins: $20.00 \n*This event will also include a 200k Challenge 2019 Info Session* \n*Free parking included*
URL:https://scienceinboston.com/event/post-seed-venture-capital-what-is-it-is-it-right-for-me-2/
LOCATION:M2D2\, 110 Canal Street\, 4th Floor\, Lowell\, MA\, 01854\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200113T150000
DTEND;TZID=America/New_York:20200113T170000
DTSTAMP:20260716T161944
CREATED:20191209T224630Z
LAST-MODIFIED:20191209T224630Z
UID:7511-1578927600-1578934800@scienceinboston.com
SUMMARY:Beyond Bits to Bytes: Looking to the Future in Imaging and Data Science
DESCRIPTION:Overview\n\nThe role of data science in life science innovation is rapidly growing and evolving. If harnessed\, the information explosion has the potential to catalyze new discoveries and treatments in healthcare to benefit patients in need. During this time of digital transformation\, the potential exists to derive value from a wide variety of data sources\, including next generation sequencing\, mass spectrometry\, electronic health records\, images\, and consumer wearables. \nThe Massachusetts Life Sciences Center (MLSC) will convene various stakeholders to discuss how data is rapidly changing patient care. The gathering will feature voices from industry and academic research partners leading in this space. The event will feature a panel discussion covering a wide range of topics\, including requirements and standards for generating useful data\, patient privacy\, barriers to adoption\, and workforce training challenges. \nThe MLSC recently launched the second round of its Bits to Bytes Capital Call to provide funding for projects that will generate and analyze large datasets to answer pressing life science questions\, and train data scientists in the Commonwealth. The inaugural round of Bits to Bytes provided $6.7 million in capital funding to nine data-driven\, cross-sector projects focused on imaging\, cancer\, neuroscience\, drug discovery and clinical trial design.
URL:https://scienceinboston.com/event/beyond-bits-to-bytes-looking-to-the-future-in-imaging-and-data-science/
LOCATION:Broad Institute of MIT and Harvard\, 415 Main Street Auditorium\, Cambridge\, MA\, 02142\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200113T150000
DTEND;TZID=America/New_York:20200113T170000
DTSTAMP:20260716T161944
CREATED:20191209T224630Z
LAST-MODIFIED:20191209T224630Z
UID:27414-1578927600-1578934800@scienceinboston.com
SUMMARY:Beyond Bits to Bytes: Looking to the Future in Imaging and Data Science
DESCRIPTION:Overview\n\nThe role of data science in life science innovation is rapidly growing and evolving. If harnessed\, the information explosion has the potential to catalyze new discoveries and treatments in healthcare to benefit patients in need. During this time of digital transformation\, the potential exists to derive value from a wide variety of data sources\, including next generation sequencing\, mass spectrometry\, electronic health records\, images\, and consumer wearables. \nThe Massachusetts Life Sciences Center (MLSC) will convene various stakeholders to discuss how data is rapidly changing patient care. The gathering will feature voices from industry and academic research partners leading in this space. The event will feature a panel discussion covering a wide range of topics\, including requirements and standards for generating useful data\, patient privacy\, barriers to adoption\, and workforce training challenges. \nThe MLSC recently launched the second round of its Bits to Bytes Capital Call to provide funding for projects that will generate and analyze large datasets to answer pressing life science questions\, and train data scientists in the Commonwealth. The inaugural round of Bits to Bytes provided $6.7 million in capital funding to nine data-driven\, cross-sector projects focused on imaging\, cancer\, neuroscience\, drug discovery and clinical trial design.
URL:https://scienceinboston.com/event/beyond-bits-to-bytes-looking-to-the-future-in-imaging-and-data-science-2/
LOCATION:Broad Institute of MIT and Harvard\, 415 Main Street Auditorium\, Cambridge\, MA\, 02142\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200114T110000
DTEND;TZID=America/New_York:20200114T130000
DTSTAMP:20260716T161944
CREATED:20191209T225541Z
LAST-MODIFIED:20191209T225541Z
UID:7514-1578999600-1579006800@scienceinboston.com
SUMMARY:Exploring accessible R-groups using electrostatics and shape
DESCRIPTION:Overview\n\nSpark™ offers a rapid strategy for the identification of R-group replacements to explore new space. We will demonstrate in this hands-on workshop how Spark finds biologically equivalent replacements using electrostatic and shape character for key moieties in your molecule. Topics covered include R-group replacement\, grow a ligand into new space\, guided by existing ligands mapping a different region of the active site of your protein. \nHands-on: If you wish to follow along in this hands-on workshop then please bring a laptop (a download link to Spark will be provided before the event if needed). \nWho should attend: Medicinal\, synthetic and computational chemists with some experience of Spark.
URL:https://scienceinboston.com/event/exploring-accessible-r-groups-using-electrostatics-and-shape/
LOCATION:CIC\, Charles Room\, 14th Floor\, CIC\, 1 Broadway\, Cambridge\, MA\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200114T110000
DTEND;TZID=America/New_York:20200114T130000
DTSTAMP:20260716T161944
CREATED:20191209T225541Z
LAST-MODIFIED:20191209T225541Z
UID:27415-1578999600-1579006800@scienceinboston.com
SUMMARY:Exploring accessible R-groups using electrostatics and shape
DESCRIPTION:Overview\n\nSpark™ offers a rapid strategy for the identification of R-group replacements to explore new space. We will demonstrate in this hands-on workshop how Spark finds biologically equivalent replacements using electrostatic and shape character for key moieties in your molecule. Topics covered include R-group replacement\, grow a ligand into new space\, guided by existing ligands mapping a different region of the active site of your protein. \nHands-on: If you wish to follow along in this hands-on workshop then please bring a laptop (a download link to Spark will be provided before the event if needed). \nWho should attend: Medicinal\, synthetic and computational chemists with some experience of Spark.
URL:https://scienceinboston.com/event/exploring-accessible-r-groups-using-electrostatics-and-shape-2/
LOCATION:CIC\, Charles Room\, 14th Floor\, CIC\, 1 Broadway\, Cambridge\, MA\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200115T080000
DTEND;TZID=America/New_York:20200117T170000
DTSTAMP:20260716T161944
CREATED:20191209T225851Z
LAST-MODIFIED:20191209T225851Z
UID:7516-1579075200-1579280400@scienceinboston.com
SUMMARY:Recombinant Antibody and Biosimilars Course
DESCRIPTION:Overview\n\nRecombinant Antibody and Biosimilars course \nDates: January 15-17\, 2020 \nLocation: \nBiopharmaceutical Analysis Training Laboratory \nNortheastern University’s Innovation Campus \n147 S. Bedford Street\, Burlington\, MA 01803 \n  \nTOPICS COVERED \n\nGlycan analysis of immunoglobulins\nN- and C-terminal variants of antibody drugs\nStudy of disulfide connectivity and monitoring disulfide exchange\nMS based analysis of PK and metabolism of multivalent antibody drugs\nAnalysis of biosimilars in terms of variants and degradation products\n\n  \nLab course will be based on 1D gel and HPLC separation and LC/MS analysis of the following samples: \n\nIntact proteins\nReduced proteins e.g heavy and light chains\nTryptic digests which will contain glyco as well as other peptides\nGlycan mixtures released by glycosidase digestion of either the glycoprotein or enzyme digest\n\n  \nCost for this 2.5 training: \n$1900 per person\, Industry and Government \n$700 per person\, Academia \n  \nFor inquiries and to register\, email us at BATL@northeastern.edu \nFor more information about Northeastern’s Biopharmaceutical Analysis Training Laboratory\, visit our website: \nhttps://www.northeastern.edu/batl
URL:https://scienceinboston.com/event/recombinant-antibody-and-biosimilars-course/
LOCATION:Biopharmaceutical Analysis Training Laboratory\, Northeastern University’s Innovation Campus\, 147 S. Bedford Street\, Burlington\, MA\, 01803\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200115T080000
DTEND;TZID=America/New_York:20200117T170000
DTSTAMP:20260716T161944
CREATED:20191209T225851Z
LAST-MODIFIED:20191209T225851Z
UID:27416-1579075200-1579280400@scienceinboston.com
SUMMARY:Recombinant Antibody and Biosimilars Course
DESCRIPTION:Overview\n\nRecombinant Antibody and Biosimilars course \nDates: January 15-17\, 2020 \nLocation: \nBiopharmaceutical Analysis Training Laboratory \nNortheastern University’s Innovation Campus \n147 S. Bedford Street\, Burlington\, MA 01803 \n  \nTOPICS COVERED \n\nGlycan analysis of immunoglobulins\nN- and C-terminal variants of antibody drugs\nStudy of disulfide connectivity and monitoring disulfide exchange\nMS based analysis of PK and metabolism of multivalent antibody drugs\nAnalysis of biosimilars in terms of variants and degradation products\n\n  \nLab course will be based on 1D gel and HPLC separation and LC/MS analysis of the following samples: \n\nIntact proteins\nReduced proteins e.g heavy and light chains\nTryptic digests which will contain glyco as well as other peptides\nGlycan mixtures released by glycosidase digestion of either the glycoprotein or enzyme digest\n\n  \nCost for this 2.5 training: \n$1900 per person\, Industry and Government \n$700 per person\, Academia \n  \nFor inquiries and to register\, email us at BATL@northeastern.edu \nFor more information about Northeastern’s Biopharmaceutical Analysis Training Laboratory\, visit our website: \nhttps://www.northeastern.edu/batl
URL:https://scienceinboston.com/event/recombinant-antibody-and-biosimilars-course-2/
LOCATION:Biopharmaceutical Analysis Training Laboratory\, Northeastern University’s Innovation Campus\, 147 S. Bedford Street\, Burlington\, MA\, 01803\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200121T180000
DTEND;TZID=America/New_York:20200121T210000
DTSTAMP:20260716T161944
CREATED:20200102T192332Z
LAST-MODIFIED:20200102T192332Z
UID:7668-1579629600-1579640400@scienceinboston.com
SUMMARY:Seed and Angel Financing for Life Science Companies – Boston
DESCRIPTION:Life sciences entrepreneurs derive from a wide variety of geographic and educational backgrounds.  Young or old(er)\, most share a strong passion for translating their ideas and data into commercial products and services to benefit human health. While the work is rewarding\, it is a tremendously challenging endeavor\, from building the team to meeting regulatory requirements. Often\, the most daunting challenge is raising the financing needed to get started. The panelists for tonight’s ENET event have deep experience in launching life science startups\, from the perspectives of founder and investor\, and they are looking forward to sharing their insights with you. Please join us for an engaging discussion and stellar networking. \nAgenda: \n6:00-7:00 PM – Registration & Networking \n7:00-7:10 PM – ENET Chairman’s Announcements \n7:10-7:25 PM – eMinute PITCH – up to 3 startups give a 90-second elevator pitch \n7:25-8:15 PM – Expert speakers on the night’s topic \n8:15-8:30 PM – Q & A \n8:30-9:00 PM – Final networking\, including meeting speakers
URL:https://scienceinboston.com/event/seed-and-angel-financing-for-life-science-companies-boston/
LOCATION:Draper\, Hill Building\, One Hampshire St.\, Cambridge\, MA\, 02139\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200121T180000
DTEND;TZID=America/New_York:20200121T210000
DTSTAMP:20260716T161944
CREATED:20200102T192332Z
LAST-MODIFIED:20200102T192332Z
UID:27425-1579629600-1579640400@scienceinboston.com
SUMMARY:Seed and Angel Financing for Life Science Companies – Boston
DESCRIPTION:Life sciences entrepreneurs derive from a wide variety of geographic and educational backgrounds.  Young or old(er)\, most share a strong passion for translating their ideas and data into commercial products and services to benefit human health. While the work is rewarding\, it is a tremendously challenging endeavor\, from building the team to meeting regulatory requirements. Often\, the most daunting challenge is raising the financing needed to get started. The panelists for tonight’s ENET event have deep experience in launching life science startups\, from the perspectives of founder and investor\, and they are looking forward to sharing their insights with you. Please join us for an engaging discussion and stellar networking. \nAgenda: \n6:00-7:00 PM – Registration & Networking \n7:00-7:10 PM – ENET Chairman’s Announcements \n7:10-7:25 PM – eMinute PITCH – up to 3 startups give a 90-second elevator pitch \n7:25-8:15 PM – Expert speakers on the night’s topic \n8:15-8:30 PM – Q & A \n8:30-9:00 PM – Final networking\, including meeting speakers
URL:https://scienceinboston.com/event/seed-and-angel-financing-for-life-science-companies-boston-2/
LOCATION:Draper\, Hill Building\, One Hampshire St.\, Cambridge\, MA\, 02139\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200122T123000
DTEND;TZID=America/New_York:20200122T130000
DTSTAMP:20260716T161944
CREATED:20191209T230217Z
LAST-MODIFIED:20191209T230217Z
UID:7519-1579696200-1579698000@scienceinboston.com
SUMMARY:Synthetic Control Arms in Clinical Trials and Regulatory Applications
DESCRIPTION:Overview\n\nAs an increasing number of rare diseases and disease subsets become tractable to novel therapies\, there is growing pressure to increase the efficiency and effectiveness of clinical trials. One such approach is the use of real-world evidence\, such as synthetic control arms. Instead of recruiting patients who have been assigned to the control arm\, a synthetic control arm can repurpose historical clinical trial or real-world data to accurately match patients. This methodology has far-ranging applications in trial design\, replacement/augmentation of control groups and identifying differentiation in treatment effects across subpopulations. \nThis webinar will discuss the methodology and applicability of synthetic control arms\, especially those utilizing large clinical trial datasets\, in biopharma R&D. We will also discuss examples where synthetic controls have successfully been used in FDA applications\, and the emerging regulatory framework.
URL:https://scienceinboston.com/event/synthetic-control-arms-in-clinical-trials-and-regulatory-applications/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200122T123000
DTEND;TZID=America/New_York:20200122T130000
DTSTAMP:20260716T161944
CREATED:20191209T230217Z
LAST-MODIFIED:20191209T230217Z
UID:27417-1579696200-1579698000@scienceinboston.com
SUMMARY:Synthetic Control Arms in Clinical Trials and Regulatory Applications
DESCRIPTION:Overview\n\nAs an increasing number of rare diseases and disease subsets become tractable to novel therapies\, there is growing pressure to increase the efficiency and effectiveness of clinical trials. One such approach is the use of real-world evidence\, such as synthetic control arms. Instead of recruiting patients who have been assigned to the control arm\, a synthetic control arm can repurpose historical clinical trial or real-world data to accurately match patients. This methodology has far-ranging applications in trial design\, replacement/augmentation of control groups and identifying differentiation in treatment effects across subpopulations. \nThis webinar will discuss the methodology and applicability of synthetic control arms\, especially those utilizing large clinical trial datasets\, in biopharma R&D. We will also discuss examples where synthetic controls have successfully been used in FDA applications\, and the emerging regulatory framework.
URL:https://scienceinboston.com/event/synthetic-control-arms-in-clinical-trials-and-regulatory-applications-2/
LOCATION:Online
END:VEVENT
END:VCALENDAR